Bioventus Inc. has announced completion of the acquisition of CartiHeal, according to a press release.
“We are excited to add CartiHeal to our diverse portfolio of active healing solutions,” Ken Reali, CEO of Bioventus, said in the release. “CartiHeal represents an important breakthrough for the treatment of osteoarthritis and osteochondral defects of the knee with significant medium- and long-term potential as evidenced by the robust data generated from its pivotal clinical trial showing superiority to current treatments.”
“We believe that the addition of